U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07624279) titled 'nVNS, CBD, and SoC for Persistent Post-Traumatic Headache' on May 29.
Brief Summary: Do cannabidiol (CBD) or vagus nerve stimulation reduce the frequency of persistent post-traumatic headache more than traditional oral headache medications?
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Persistent Post Traumatic Headache
Intervention:
DEVICE: Non-Invasive Vagus Nerve Stimulation
Two treatments to the cervical vagus nerve twice daily
DRUG: Cannabidiol
Dosage titrated as per schedule
DRUG: Standard of Care
Oral pharmacotherapy as selected by site investigator and participant
Recruitment Status: NOT_YET_RECR...